NGM Biopharmaceuticals Lands $20,710,000 Series D Funding

  • Feed Type
  • Date
  • Company Name
    NGM Biopharmaceuticals
  • Mailing Address
    630 Gateway Blvd South San Francisco, CA 94080 USA
  • Company Description
    NGM is a privately-held drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity, muscle wasting and other cardiometabolic diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy